脳深部刺激装置 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の脳深部刺激装置（DBS）の市場規模は、2023年に13億1,000万米ドル、2030年までに23億7,000万米ドルに達し、2024年～2030年の予測期間にCAGRで10.40％の成長が見込まれます。脳深部刺激装置の需要は、パーキンソン病などの運動障害の有病率の増加、DBS治療の適応疾患の拡大、老年人口の増加、製品開発における研究開発活動の活発化などにより成長を示しており、予測期間に市場の成長につながる見込みです。

脳深部刺激装置の市場力学

DBS装置市場は、パーキンソン病、ジストニア、振戦などのさまざまな運動障害の有病率の上昇により、市場収益の増加を見せています。International Parkinson and Movement Disorder Societyが提供したデータによると、2020年に世界人口の約940万人がパーキンソン病に罹患していると推定されています。パーキンソン病は、振戦や姿勢不安定から、動作の硬直や平衡感覚の欠如に至るまで、さまざまな臨床症状を伴います。脳深部刺激はパーキンソン病の治療において有益な結果をもたらすことが報告されており、DBS装置による神経細胞の標的刺激が症状の緩和に役立っています。そのため、パーキンソン病患者数の増加によりDBS装置に対する需要が増加し、予測期間（2024年～2030年）における脳深部刺激装置市場のプラス成長が見込まれます。

DBS装置の需要の増加につながるもう1つの主な要因は、世界中でのてんかん患者数の増加です。世界保健機関（WHO）が提供したデータによると、2019年に世界中で5,000万人近くがてんかんを患っており、世界でもっとも一般的な神経疾患の1つとなっています。てんかんはさまざまな長さの発作を繰り返すことが特徴です。脳深部刺激は、薬物療法が効かず、てんかん手術を受ける資格がないてんかん患者にとって有益であることが報告されています。したがって、てんかん人口の増加もDBS装置の需要を促進し、ひいては脳深部刺激装置市場の成長につながると予測されます。

前述のパラメーターに加え、老年人口の増加、DBS装置で治療される適応症の拡大、非常に活発な脳深部刺激製品の研究開発なども、予測期間に脳深部刺激システム市場を積極的に刺激する主な要因です。

しかし、DBS装置の設置手術に伴う合併症や、市場におけるエンドユーザー向けのDBSシステムの限られた選択肢は、DBS装置市場の成長に対する特定の抑制要因になる可能性があります。

前述の要因に加え、脳深部刺激療法市場は、COVID-19の蔓延を抑制するために必要な措置としてロックダウンが課されたため、一時的に後退した時期がありました。この間の主な措置の1つは、多くの選択的手術と外来受診の停止で、これにより市場におけるDBS装置の需要が減少し、市場成長が短期間制限されました。とはいえ脳深部刺激装置市場は、世界中で多数のCOVID-19ワクチンが承認および投与されたことにより、医療サービスを含むさまざまな領域で活動が再開され、回復期にあります。

脳深部刺激装置市場のセグメント分析

脳深部刺激装置市場の製品タイプセグメントでは、デュアルチャネル脳深部刺激システムが予測期間に突出した市場シェアを占めると推定されます。これは、デュアルチャネル神経刺激装置が2つの独立したDBSリードを備えており、患者への両側の治療をもたらすことに起因すると考えられます。デュアルチャネルDBSシステムの留置は切開の回数が少なく、エクステンションのトンネリングも少なく済むため、シングルチャネルDBSシステムよりも有利であることが証明されています。このように、上記の要因は予測期間にデュアルチャネルDBS装置の需要にプラスの影響を与え、予測期間に脳深部刺激装置市場の全体的な成長に寄与する見込みです。

北米は脳深部刺激装置市場全体を独占すると予測されます。

すべての地域の中で、北米がDBS装置市場で大きな市場シェアを占めると予測されています。北米が圧倒的な市場シェアを占めると予測される理由は、運動障害や強迫性障害（OCD）などの適応症の高い有病率や、それらの疾患と可能な治療法に関する認知の向上、老年人口の増加、運動障害や治療に関する認知度を高める政府の取り組みの活発化などであり、これらが北米の脳深部刺激装置市場の成長を後押しすると予測されます。さらに、高い可処分所得、精巧な医療インフラ、新製品の承認、製品開発の進行も、この地域の市場成長を後押ししています。

当レポートでは、世界の脳深部刺激装置市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脳深部刺激装置市場レポートのイントロダクション

第2章 脳深部刺激装置市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制と特許の分析

• 米国
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
• 日本

第4章 脳深部刺激装置市場の主な要因の分析

• 脳深部刺激装置市場の促進要因
  • 運動障害の有病率の上昇
  • DBS療法の適応疾患の拡大
  • 老年人口の増加
  • DBS装置の製品設計と機能の向上
• 脳深部刺激装置市場の抑制要因と課題
  • DBS手術に伴う合併症
  • エンドユーザー向けDBSシステムの限られた選択肢
• 脳深部刺激装置市場の機会
  • 新興市場をターゲットにした製品の発売
  • 製品の安全面の向上

第5章 脳深部刺激装置市場のポーターのファイブフォース分析

第6章 脳深部刺激装置市場に対するCOVID-19の影響の分析

第7章 脳深部刺激装置市場のレイアウト

• 製品タイプ別
  • シングルチャネルDBS装置
  • デュアルチャネルDBS装置
• 電池タイプ別
  • 充電式
  • 非充電式
• 用途別
  • パーキンソン病
  • てんかん
  • 強迫性障害
  • ジストニア
  • その他
• エンドユーザー別
  • 病院
  • 専門クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 脳深部刺激装置市場：世界の企業シェア分析 - 主要3～5社

第9章 脳深部刺激装置市場の企業と製品のプロファイル

• Abbott
• Medtronic
• Boston Scientific Corporation
• ALEVA NEUROTHERAPEUTICS SA.
• Beijing PINS Medical Co., Ltd.
• Newronika S.p.A.

第10章 プロジェクトのアプローチ

• 二次資料
• 一次資料
• データの三角測量
• 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis
• Table 3 Dep Brain Stimulation Devices in Global (2021-2030)
• Table 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
• Table 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
• Table 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
• Table 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
• Table 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
• Table 9 Deep Brain Stimulation Devices in North America (2021-2030)
• Table 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
• Table 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
• Table 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
• Table 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
• Table 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
• Table 15 Deep Brain Stimulation Devices in the US (2021-2030)
• Table 16 Deep Brain Stimulation Devices in Canada (2021-2030)
• Table 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
• Table 18 Deep Brain Stimulation Devices in Europe (2021-2030)
• Table 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
• Table 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
• Table 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
• Table 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
• Table 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
• Table 24 Deep Brain Stimulation Devices in France (2021-2030)
• Table 25 Deep Brain Stimulation Devices in Germany (2021-2030)
• Table 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
• Table 27 Deep Brain Stimulation Devices in Italy (2021-2030)
• Table 28 Deep Brain Stimulation Devices in Spain (2021-2030)
• Table 29 Deep Brain Stimulation Devices in Russia (2021-2030)
• Table 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
• Table 31 Deep Brain Stimulation Devices in APAC (2021-2030)
• Table 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
• Table 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
• Table 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
• Table 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
• Table 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
• Table 37 Deep Brain Stimulation Devices in China (2021-2030)
• Table 38 Deep Brain Stimulation Devices in Japan (2021-2030)
• Table 39 Deep Brain Stimulation Devices in India (2021-2030)
• Table 40 Deep Brain Stimulation Devices in Australia (2021-2030)
• Table 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
• Table 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
• Table 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
• Table 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
• Table 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
• Table 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
• Table 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
• Table 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
• Table 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
• Table 50 Deep Brain Stimulation Devices in Africa (2021-2030)
• Table 51 Deep Brain Stimulation Devices in South America (2021-2030)

List of Figures

• Figure 1 Competitive Analysis
• Figure 2 COVID-19 Impact Analysis
• Figure 3 Deep Brain Stimulation Devices in Global (2021-2030)
• Figure 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
• Figure 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
• Figure 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
• Figure 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
• Figure 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
• Figure 9 Deep Brain Stimulation Devices in North America (2021-2030)
• Figure 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
• Figure 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
• Figure 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
• Figure 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
• Figure 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
• Figure 15 Deep Brain Stimulation Devices in the US (2021-2030)
• Figure 16 Deep Brain Stimulation Devices in Canada (2021-2030)
• Figure 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
• Figure 18 Deep Brain Stimulation Devices in Europe (2021-2030)
• Figure 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
• Figure 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
• Figure 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
• Figure 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
• Figure 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
• Figure 24 Deep Brain Stimulation Devices in France (2021-2030)
• Figure 25 Deep Brain Stimulation Devices in Germany (2021-2030)
• Figure 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
• Figure 27 Deep Brain Stimulation Devices in Italy (2021-2030)
• Figure 28 Deep Brain Stimulation Devices in Spain (2021-2030)
• Figure 29 Deep Brain Stimulation Devices in Russia (2021-2030)
• Figure 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
• Figure 31 Deep Brain Stimulation Devices in APAC (2021-2030)
• Figure 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
• Figure 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
• Figure 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
• Figure 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
• Figure 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
• Figure 37 Deep Brain Stimulation Devices in China (2021-2030)
• Figure 38 Deep Brain Stimulation Devices in Japan (2021-2030)
• Figure 39 Deep Brain Stimulation Devices in India (2021-2030)
• Figure 40 Deep Brain Stimulation Devices in Australia (2021-2030)
• Figure 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
• Figure 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
• Figure 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
• Figure 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
• Figure 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
• Figure 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
• Figure 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
• Figure 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
• Figure 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
• Figure 50 Deep Brain Stimulation Devices in Africa (2021-2030)
• Figure 51 Deep Brain Stimulation Devices in South America (2021-2030)
• Figure 52 Market Drivers
• Figure 53 Market Barriers
• Figure 54 Marker Opportunities
• Figure 55 PORTER'S Five Force Analysis

Deep Brain Stimulation Devices Market By Product Type (Single Channel And Dual Channel), By Battery Type (Rechargeable And Non-Rechargeable), By Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, And Others), By End User (Hospitals And Specialty Clinics), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of parkinson's disease and epilepsy.

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030. The demand for deep brain stimulation devices is witnessing growth owing to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Dynamics:

The DBS devices market is witnessing an increase in market revenue owing to the rising prevalence of various movement disorders such as Parkinson's disease, dystonia and tremors among others. According to the data provided by the International Parkinson and Movement Disorder Society, it was estimated that in 2020, approximately 9.4 million of the global population was suffering from Parkinson's disease. Parkinson's disease is associated with a variety of clinical manifestations ranging from tremors and postural instability to rigidity in movement and lack of balance. Deep brain stimulation has been reported to provide beneficial outcomes in the treatment of Parkinson's disease, wherein targeted stimulation of neurons by DBS devices help in the alleviation of symptoms. Therefore, the demand for DBS devices is set to increase due to the rising number of Parkinson's disease patients, thereby projecting positive growth for the deep brain stimulation devices market during the forecast period (2024-2030).

Another key factor leading to the increased demand for the DBS devices is the increase in the prevalent population of epilepsy patients across the globe. As per the data provided by the World Health Organization, in 2019, near about 50 million people across the world had epilepsy making it one of the most common neurological diseases in the world. Epilepsy is characterized by recurrent seizures of varying lengths. Deep brain stimulation has been reported to be beneficial for epilepsy patients who have not been benefitted from medications and do not qualify for epilepsy surgery. Therefore, the rising epileptic population is also expected to drive the demand for DBS devices, which in turn would result in the growth of the deep brain stimulation devices market.

Along with the aforementioned parameters, the rising geriatric population, expansion of indications to be treated with DBS devices and the highly active research and development area for the deep brain stimulation products are some of the other key contributing factors which will stimulate the deep brain stimulation systems market positively during the forecast period.

However, complications associated with the DBS devices placement surgery, limited options of DBS systems for end users in the market may prove to be certain restraints to the DBS devices market growth.

In addition to the previously mentioned factors, the deep brain stimulation market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for DBS devices in the market, thereby limiting the market growth for a short time. Nevertheless, the market for deep brain stimulation devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Segment Analysis:

Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), by Battery Type (Rechargeable and Non-Rechargeable), by Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the deep brain stimulation devices market, the dual channel deep brain stimulation systems are estimated to account for the prominent market share during the forecast period. This can be ascribed to the fact that dual channel neurostimulators are equipped with two separate DBS leads which enable the devices to provide bilateral therapy to patients. The placement of dual channel DBS systems require fewer incisions and less tunneling of extensions which prove to be advantageous over single-channel DBS systems. Thus, the factors mentioned above are going to influence the demand for dual channel DBS devices positively during the forecast period, thereby contributing in the overall growth of the deep brain stimulation devices market during the forecast period.

North Amercia is expected to dominate the overall Deep Brain Stimulation Devices Market:

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

The North American DBS devices market is witnessing an upward trend due to the rising prevalence of obsessive compulsive disorder among other factors. As per the data provided by the Anxiety & Depression Association of America, in 2020, near about 2.2 million people were diagnosed with OCD in the United States. It has been reported in many studies that deep brain stimulation has proven to be beneficial in alleviating OCD symptoms in patients. Therefore, the increase in patient population of OCD in the United States is expected to aid in the growing demand for DBS devices, which in turn in expected to drive the growth of the United States deep brain stimulation devices market.

Besides United States, the demand for DBS devices is set to increase in other North American countries such as Canada also due to the increase in patient population of movement disorders such as Parkinson's disease. According to the data provided by a Canada-based organization-Parkinson Canada, in 2020, approximately 100,000 people were living were PD in the country. The data further stated that from the current average of 25 Canadians being diagnosed with Parkinson's disease each day, the average is expected to rise to 50 people per day by 2031. Therefore, the estimates regarding the increase in patient population of PD in Canada would lead to the increase in demand for deep brain stimulation devices, thereby providing a positive market outlook for the DBS systems market during the forecast period.

Along with the factors mentioned above, the conducive environment for product development and launches in the country further motivates the market players to enhance their presence in North America. For instance, in 2018, the US Food and Drug Administration approved DBS therapy for epilepsy thereby expanding the scope of indications, which in turn is expected to contribute to the increase in product demand thereby supporting the growth of the North America DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Key Players:

Some of the key market players operating in the DBS devices market includes Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

Recent Developmental Activities in Deep Brain Stimulation Devices Market:

In June 2022, Medtronic received the product approval by the US Food and Drug Administration for First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy.

In January 2022, Boston Scientific received the product approval from the US FDA for their fourth generation Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

In September 2020, Boston Scientific received the CE mark approval from the Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

Key Takeaways from the Deep Brain Stimulation Devices Market Report Study

Market size analysis for current DBS devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the DBS devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global DBS devices market.

Various opportunities available for the other competitor in the DBS devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current DBS devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for DBS devices market growth in the coming future?

Target Audience who can be benefited from this Deep Brain Stimulation Devices Market Report Study

Deep Brain Stimulation Devices products providers

Research organizations and consulting companies

Deep Brain Stimulation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in DBS devices

Various End-users who want to know more about the DBS devices market and latest technological developments in the DBS devices market.

Frequently Asked Questions for Deep Brain Stimulation Devices Market:

1. What is a Deep Brain Stimulation Device?

Deep brain stimulation (DBS) is a device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device. The device design in identical to that of a heart pacemaker.

2. What is the market for Global Deep Brain Stimulation Devices?

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030.

3. What are the drivers for Global Deep Brain Stimulation Devices Market?

The demand for deep brain stimulation devices is witnessing growth due to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market in the forecast period.

4. Who are the key players operating in Global Deep Brain Stimulation Devices Market?

Some of the key market players operating in the Global DBS systems market are Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

5. Which region has the highest share in Deep Brain Stimulation Devices market?

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

Table of Contents

1. Deep Brain Stimulation Devices Market Report Introduction

2. Deep Brain Stimulation Devices Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
  • 3.2.1 Germany
  • 3.2.2 France
  • 3.2.3 Italy
  • 3.2.4 Spain
  • 3.2.5 U.K.
• 3.3 Japan

4. Deep Brain Stimulation Devices Market Key Factors Analysis

• 4.1 Deep Brain Stimulation Devices Market Drivers
  • 4.1.1 Rising Prevalence of Movement Disorders
  • 4.1.2 Expansion of Disease Indications for DBS Therapy
  • 4.1.3 Rising Geriatric Population
  • 4.1.4 Improving Product Design and Features of DBS Devices
• 4.2 Deep Brain Stimulation Devices Market Restraints and Challenges
  • 4.2.1 Complications Associated with DBS Procedures
  • 4.2.2 Limited Options of DBS Systems for End Users
• 4.3 Deep Brain Stimulation Devices Market Opportunities
  • 4.3.1 Targeting Emerging Markets for Product Launches
  • 4.3.2 Product Improvement in Terms of Safety

5. Deep Brain Stimulation Devices Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Deep Brain Stimulation Devices Market

7. Deep Brain Stimulation Devices Market Layout

• 7.1 By Product Type
  • 7.1.1 Single-Channel DBS Devices
  • 7.1.2 Dual-Channel DBS Devices
• 7.2 By Battery Type
  • 7.2.1 Rechargeable
  • 7.2.2 Non-rechargeable
• 7.3 By Application
  • 7.3.1 Parkinson's Disease
  • 7.3.2 Epilepsy
  • 7.3.3 Obsessive Compulsive Disorder
  • 7.3.4 Dystonia
  • 7.3.5 Others
• 7.4 By End User
  • 7.4.1 Hospitals
  • 7.4.2 Specialty Clinics
• 7.5 By Geography
  • 7.5.1 North America
    • 7.5.1.1 North America Deep Brain Stimulation Devices Market, by Product Type
    • 7.5.1.2 North America Deep Brain Stimulation Devices Market, by Battery Type
    • 7.5.1.3 North America Deep Brain Stimulation Devices Market, by Application
    • 7.5.1.4 North America Deep Brain Stimulation Devices Market, by End User
    • 7.5.1.5 North America Deep Brain Stimulation Devices Market, by Country
    • 7.5.1.5.1 United States
    • 7.5.1.5.2 Canada
    • 7.5.1.5.3 Mexico
  • 7.5.2 Europe
    • 7.5.2.1 Europe Deep Brain Stimulation Devices Market, by Product Type
    • 7.5.2.2 Europe Deep Brain Stimulation Devices Market, by Battery Type
    • 7.5.2.3 Europe Deep Brain Stimulation Devices Market, by Application
    • 7.5.2.4 Europe Deep Brain Stimulation Devices Market, by End User
    • 7.5.2.5 Europe Deep Brain Stimulation Devices Market, by Country
    • 7.5.2.5.1 France
    • 7.5.2.5.2 Germany
    • 7.5.2.5.3 United Kingdom
    • 7.5.2.5.4 Italy
    • 7.5.2.5.5 Spain
    • 7.5.2.5.6 Russia
    • 7.5.2.5.7 Rest of Europe
  • 7.5.3 Asia-Pacific
    • 7.5.3.1 Asia-Pacific Deep Brain Stimulation Devices Market, by Product Type
    • 7.5.3.2 Asia-Pacific Deep Brain Stimulation Devices Market, by Battery Type
    • 7.5.3.3 Asia-Pacific Deep Brain Stimulation Devices Market, by Application
    • 7.5.3.4 Asia-Pacific Deep Brain Stimulation Devices Market, by End User
    • 7.5.3.5 Asia-Pacific Deep Brain Stimulation Devices Market, by Country
    • 7.5.3.5.1 China
    • 7.5.3.5.2 Japan
    • 7.5.3.5.3 India
    • 7.5.3.5.4 Australia
    • 7.5.3.5.5 South Korea
    • 7.5.3.5.6 Rest of Asia Pacific
  • 7.5.4 Rest of the World (RoW)
    • 7.5.4.1 RoW Deep Brain Stimulation Devices Market, by Product Type
    • 7.5.4.2 RoW Deep Brain Stimulation Devices Market, by Battery Type
    • 7.5.4.3 RoW Deep Brain Stimulation Devices Market, by Application
    • 7.5.4.4 RoW Deep Brain Stimulation Devices Market, by End User
    • 7.5.4.5 RoW Deep Brain Stimulation Devices Market, by Country
    • 7.5.4.5.1 Middle East
    • 7.5.4.5.2 Africa
    • 7.5.4.5.3 South America

8. Deep Brain Stimulation Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Deep Brain Stimulation Devices Market Company and Product Profiles

• 9.1 Abbott
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 Medtronic
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Boston Scientific Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 ALEVA NEUROTHERAPEUTICS SA.
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Beijing PINS Medical Co., Ltd.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Newronika S.p.A.,
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy

10. PROJECT APPROACH

• 10.1 Secondary Sources
• 10.2 Primary Sources
• 10.3 Data Triangulation
• 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight